Herbalife’s 3.1x P/E Masks a 5-Year 80% Plunge

Forward-Looking Analysis

Current market data does not contain specific revenue, net profit, or EPS estimates for Herbalife’s 2026Q2 earnings report scheduled for August 5th, 2026. Consequently, no projected financial figures or bank predictions can be synthesized for this specific quarter. However, based on available analyst sentiment from the provided dataset, 11 analysts cover the stock, with 45.45% recommending a 'BUY' rating and 45.45% recommending a 'Hold'. The average analyst target price is set at $9.33. This target implies a potential downside of -5.57% relative to the recent trading price of $9.85. The consensus suggests limited immediate upside potential based on current valuations, with the stock trading at a P/E ratio of 3.10x, significantly lower than the industry average of 13.38x. No specific upgrades or downgrades for the 2026Q2 period are cited in the provided text.

Historical Performance Review

Herbalife delivered strong results in 2026Q1, reporting revenue of $1.32 billion and net income of $61.20 million. Earnings per share (EPS) reached $0.60, while gross profit stood at $1.03 billion. This performance demonstrates robust top-line growth and healthy gross margins, indicating effective cost management and sustained demand for the company's nutrition and weight-management products during the first quarter of 2026.

Additional News

Herbalife Ltd. (HLF) is currently trading at $9.85, reflecting a 2.43% decline from its previous close of $10.09. The stock has experienced significant volatility over the past year, hitting a 52-week low of $5.04 in February 2025 and a high of $10.83 in July 2025. Despite a challenging 3-year return of -59.29% and a 5-year return of -80.02%, the stock has shown recent momentum with a 1-month return of +6.59% and a 3-month return of +28.05%. Over the last year, HLF outperformed top peers in its industry. Fundamentally, the company exhibits a low P/E ratio of 3.10x compared to the industry average of 13.38x, though its PEG ratio is negative at -32.8. Quarterly earnings growth has been positive year-over-year at 9.27%, and revenue has increased for the last three quarters. Key institutional holders include Vanguard Group Inc (12.12%) and BlackRock Inc (7.61%). CEO Stephan Paulo Gratziani leads the global nutrition company, which operates in over 90 countries with more than 7,500 employees.

Summary & Outlook

Herbalife exhibits mixed financial health, characterized by strong recent quarterly revenue growth and positive year-over-year earnings growth, yet weighed down by severe long-term underperformance. The company’s valuation remains exceptionally low relative to peers, suggesting potential undervaluation or market skepticism regarding future sustainability. While the immediate catalyst is the upcoming earnings report, the broader outlook is neutral to cautiously bullish due to the significant discount to industry multiples. However, risks persist given the negative PEG ratio and historical price declines. Investors should monitor the 2026Q2 results for evidence of sustained margin expansion and revenue stability to confirm a turnaround in long-term investor confidence.